올릭스 주식회사

{
  "address": "경기 성남시",
  "ceo_name": "이동기",
  "certificate": [
    {
      "cert_number": "20100106826",
      "changes": "",
      "disclosure_date": "2010-09-17",
      "first_cert_date": "2010-09-17",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2010-09-17 ~ 2012-09-16"
    },
    {
      "cert_number": "20120108967",
      "changes": "",
      "disclosure_date": "2012-11-15",
      "first_cert_date": "2010-09-17",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2012-09-17 ~ 2014-09-16"
    },
    {
      "cert_number": "20140111146",
      "changes": "",
      "disclosure_date": "2014-10-14",
      "first_cert_date": "2010-09-17",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-09-17 ~ 2016-09-16"
    },
    {
      "cert_number": "20160300405",
      "changes": "",
      "disclosure_date": "2016-08-18",
      "first_cert_date": "2010-09-17",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2016-09-17 ~ 2018-09-16"
    },
    {
      "cert_number": "20180300638",
      "changes": "",
      "disclosure_date": "2018-09-20",
      "first_cert_date": "2010-09-17",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2018-09-17 ~ 2020-09-16"
    },
    {
      "cert_number": "20200111459",
      "changes": "",
      "disclosure_date": "2020-09-01",
      "first_cert_date": "2010-09-17",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2020-09-17 ~ 2022-09-16"
    },
    {
      "cert_number": "20220818010029",
      "changes": "",
      "disclosure_date": "2022-08-18",
      "first_cert_date": "2010-09-17",
      "no": "7",
      "type": "벤처투자유형",
      "valid_period": "2022-09-17 ~ 2025-09-16"
    },
    {
      "cert_number": "20250903010014",
      "changes": "",
      "disclosure_date": "2025-09-03",
      "first_cert_date": "2010-09-17",
      "no": "8",
      "type": "벤처투자유형",
      "valid_period": "2025-09-17 ~ 2028-09-16"
    }
  ],
  "company_name": "올릭스 주식회사",
  "corp_no": "135811-*******",
  "financials": {
    "2022": {
      "capital_stock": 8351584000,
      "cost_of_sales": 0,
      "current_assets": 62003630000,
      "current_liabilities": 40059991000,
      "gross_profit": 9490673000,
      "net_income": -21082020000,
      "net_income_bs": -19991318000,
      "non_current_assets": 68714095000,
      "non_current_liabilities": 23128540000,
      "non_operating_expenses": 8529167000,
      "non_operating_income": 10096957000,
      "operating_profit": -22649810000,
      "revenue": 9490673000,
      "sga_expenses": 32140482000,
      "total_assets": 130717725000,
      "total_equity": 67529195000,
      "total_liabilities": 63188531000
    },
    "2023": {
      "capital_stock": 8446735000,
      "cost_of_sales": 0,
      "current_assets": 27363996000,
      "current_liabilities": 7251059000,
      "gross_profit": 16434778000,
      "net_income": -18981429000,
      "net_income_bs": -19862434000,
      "non_current_assets": 73536967000,
      "non_current_liabilities": 43007671000,
      "non_operating_expenses": 7742875000,
      "non_operating_income": 6629125000,
      "operating_profit": -17867679000,
      "revenue": 16434778000,
      "sga_expenses": 34302457000,
      "total_assets": 100900963000,
      "total_equity": 50642233000,
      "total_liabilities": 50258730000
    },
    "2024": {
      "capital_stock": 9229787000,
      "cost_of_sales": 0,
      "current_assets": 11543116000,
      "current_liabilities": 33780381000,
      "gross_profit": 5677152000,
      "net_income": -41477860000,
      "net_income_bs": -41008938000,
      "non_current_assets": 62388956000,
      "non_current_liabilities": 22716238000,
      "non_operating_expenses": 21252676000,
      "non_operating_income": 5502804000,
      "operating_profit": -25727988000,
      "revenue": 5677152000,
      "sga_expenses": 31405140000,
      "total_assets": 73932072000,
      "total_equity": 17435454000,
      "total_liabilities": 56496619000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "9,999,989,317",
      "changes": "9,999,989,317",
      "date": "2022-05-31"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2022-05-31"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2022-05-31"
    },
    {
      "amount": "5,100,000,000",
      "changes": "5,100,000,000",
      "date": "2022-05-31"
    },
    {
      "amount": "4,900,000,000",
      "changes": "4,900,000,000",
      "date": "2022-05-31"
    },
    {
      "amount": "4,000,000,000",
      "changes": "4,000,000,000",
      "date": "2022-05-31"
    },
    {
      "amount": "6,000,000,000",
      "changes": "6,000,000,000",
      "date": "2022-05-31"
    },
    {
      "amount": "10,000,000,000",
      "changes": "10,000,000,000",
      "date": "2022-05-31"
    },
    {
      "amount": "1,312,839,000",
      "changes": "1,312,839,000",
      "date": "2017-11-22"
    }
  ],
  "main_products": "siRNA 신약,의학(핵산치료제),신약,의약품 연구개발/부동산 임대",
  "phone": "031-779-****",
  "years": [
    2024,
    2023,
    2022
  ]
}